Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Akela Pharma Inc. AKLPF

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."

Bullboard (GREY:AKLPF)

View:
Post by Biostocks01on Jan 13, 2013 11:22am

Pharmaform

Formulation Technologies, L.L.C, doing business as PharmaForm LLC pharmaform is now a private company, frustrating for shareholders Akela Bio
Comment by smush74on Dec 26, 2012 4:13pm

RE: NOTICE

Great work Luc and thank you, I have contacted PharmaForm and asked if they could inform exactly what their relationship with AKL is as we both seem to be getting nowhere here in Canada. I am now ...more  
Comment by smush74on Dec 26, 2012 1:22pm

RE: NOTICE

Great work Luc and thank you, I have contacted PharmaForm and asked if they could inform exactly what their relationship with AKL is as we both seem to be getting nowhere here in Canada. I am now ...more  
Post by modulexon Dec 19, 2012 6:41pm

NOTICE

December 19, 2012 Mrs. Brenda Leong Chair and Chief Executive Officer British Columbia Securities Commission PO Box 10142, Pacific Centre 701 West Georgia ...more  
Post by frenchy08on Dec 12, 2012 2:33pm

TRADING ON ITRADE

x AKL Akela Pharma Inc 0.01 CAD -0.005 (-33.33%) 0.00(0) 0.00(0) 81.66K
Post by frenchy08on Dec 12, 2012 2:29pm

Trading

We're trading again?????
Comment by Biostocks01on Dec 11, 2012 7:47pm

RE: AKELA PHARMA INC.

GREAT JOB...Luc!! Bio
Post by modulexon Dec 11, 2012 6:45pm

AKELA PHARMA INC.

December 11, 2012British Columbia Securities Commission 701 West Georgia Street P.O. Box 10142, Pacific Centre Vancouver, B.C. V7Y 1L2 To Whom it may Concern:The Ontario Securities ...more  
Post by modulexon Dec 09, 2012 11:22am

AKELA PHARMA INC.

December 9, 2012 Mrs. Livia Legault CA Registered Office and Head Office of TMX Group The Exchange ...more  
Post by SH0RTBUSon Dec 07, 2012 6:44pm

So long to this POS

Now we're not even going to get our penny a share out of it.
Post by Biostocks01on Dec 07, 2012 6:05pm

Akela Pharma Inc.

Akela Pharma, Inc. delists from the Toronto Stock Exchange   16:09 EST Friday, Dec 07, 2012   VANCOUVER, Dec. 7, 2012/CNW Telbec/ - Akela Pharma, Inc. (TSX: AKL) (the "Corporation ...more  
Comment by Biostocks01on Dec 01, 2012 5:53pm

RE: AKELA PHARMA - VOLUNTARY DELISTING

 I saw the news last night too ... I'll contact the AMF to know our resort as the company completely ignores its shareholders. I will also contact the CEO to find out more about this ...more  
Post by modulexon Dec 01, 2012 11:17am

AKELA PHARMA - VOLUNTARY DELISTING

CNW Group November 30, 2012 7:30 PM Akela Pharma, Inc. announces voluntary delisting from the Toronto Stock Exchange VANCOUVER, Nov. 30 ...more  
Post by modulexon Dec 01, 2012 10:54am

INQUIRIES@OSC.GOV.ON.CA

December 1, 2012 Registered Office and Head Office of TMX Group The Exchange Tower 130 King Street West Toronto, ON M5X 1J2 RE ...more  
Post by modulexon Nov 30, 2012 6:32pm

NOTE

November 30, 2012 Mr. Rudy J. Emmelot President and Chief Executive Officer Akela Pharma Inc. Mr. Emmelot: While doing my year-end 2012 financial review this morning, I ...more